Back to Oregon

SB447 • 2025

Requires a pharmacy to notify a person to whom a prescription drug is dispensed that the drug manufacturer may offer a patient assistance program.

Requires a pharmacy to notify a person to whom a prescription drug is dispensed that the drug manufacturer may offer a patient assistance program.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Senator Patterson
Last action
2025-06-27
Official status
In Senate Committee
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Requires a pharmacy to notify a person to whom a prescription drug is dispensed that the drug manufacturer may offer a patient assistance program.

Digest: The Act says that a pharmacy has to tell a person who gets a prescription drug that the drug maker might be able to help the person pay for the drug.

What This Bill Does

  • Digest: The Act says that a pharmacy has to tell a person who gets a prescription drug that the drug maker might be able to help the person pay for the drug.
  • (Flesch Readability Score: 68.9).
  • Requires a pharmacy to notify a person to whom a prescription drug is dispensed that the drug manufacturer may offer a patient assistance program.
  • Defines "patient assistance program." Takes effect on the 91st day following adjournment sine die.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2025-06-27 Senate

    In committee upon adjournment.

  2. 2025-01-17 Senate

    Referred to Health Care.

  3. 2025-01-13 Senate

    Introduction and first reading. Referred to President's desk.

Official Summary Text

Digest: The Act says that a pharmacy has to tell a person who gets a prescription drug that the drug maker might be able to help the person pay for the drug. (Flesch Readability Score: 68.9).
Requires a pharmacy to notify a person to whom a prescription drug is dispensed that the drug manufacturer may offer a patient assistance program. Defines "patient assistance program."
Takes effect on the 91st day following adjournment sine die.
Relating to: Relating to patient assistance programs; prescribing an effective date.
Current location: In Senate Committee

Current Bill Text

Read the full stored bill text
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session
Senate Bill 447
Sponsored by Senator PATTERSON (Presession filed.)
SUMMARY
The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject
to consideration by the Legislative Assembly. It is an editor’s brief statement of the essential features of the
measure as introduced. The statement includes a measure digest written in compliance with applicable readability
standards.
Digest: The Act says that a pharmacy has to tell a person who gets a prescription drug that the
drug maker might be able to help the person pay for the drug. (Flesch Readability Score: 68.9).
Requires a pharmacy to notify a person to whom a prescription drug is dispensed that the drug
manufacturer may offer a patient assistance program. Defines “patient assistance program.”
Takes effect on the 91st day following adjournment sine die.
A BILL FOR AN ACT
Relating to patient assistance programs; and prescribing an effective date.
Be It Enacted by the People of the State of Oregon:
SECTION 1.
Section 2 of this 2025 Act is added to and made a part of ORS chapter 689.
SECTION 2. (1) As used in this section, “patient assistance program” means a program
operated by or on behalf of a manufacturer that offers financial assistance to a person to
whom a drug manufactured by the manufacturer is dispensed.
(2) A pharmacy shall notify each person to whom a prescription drug is dispensed that
a patient assistance program may be available from the drug’s manufacturer and provide to
the patient the name of the manufacturer.
(3) Subsection (2) of this section does not apply to an institutional drug outlet.
SECTION 3.
Section 2 of this 2025 Act applies to prescription drugs dispensed on or after
the operative date specified in section 4 of this 2025 Act.
SECTION 4. (1) Section 2 of this 2025 Act becomes operative on January 1, 2026.
(2) The State Board of Pharmacy may take any action before the operative date specified
in subsection (1) of this section that is necessary to enable the board to exercise, on and
after the operative date specified in subsection (1) of this section, all of the duties, functions
and powers conferred on the board by section 2 of this 2025 Act.
SECTION 5. This 2025 Act takes effect on the 91st day after the date on which the 2025
regular session of the Eighty-third Legislative Assembly adjourns sine die.
NOTE: Matter in boldfaced type in an amended section is new; matter [ italic and bracketed] is existing law to be omitted.
New sections are in boldfaced type.
LC 1118